Last Updated on February 9, 2026 10:50 pm by BIZNAMA NEWS
AMN / BIZ DESK
The Indian equity markets kicked off the week on a bullish note this Monday, February 9, 2026, driven by stellar corporate earnings and a wave of optimism surrounding the landmark India-US Interim Trade Agreement (ITA). Both the BSE Sensex and NSE Nifty 50 posted healthy gains, closing up 0.58% and 0.68% respectively.
Market Performance Summary
The rally was spearheaded by State Bank of India (SBI), which surged over 7% following robust Q3 results. This optimism trickled down into the broader markets, where midcap and smallcap stocks significantly outperformed the benchmarks, gaining 1.58% and 2.64% respectively. This “sea of green” was further supported by a decline in global oil prices (Brent crude at $67.52) and strong institutional buying.
Sector-Wise Performance
| Sector | Impact | Key Drivers |
| PSU Banks | 🟢 Top Performer (>3%) | SBI’s earnings rally triggered massive buying across state-run lenders. |
| Media & Durables | 🟢 Strong Gains (>3%) | Upbeat consumer sentiment and positive trade outlooks boosted these sectors. |
| Metals & Cement | 🟢 Positive | Tata Steel and UltraTech Cement gained on infrastructure and trade optimism. |
| Energy & Utilities | 🔴 Laggards | Power Grid and NTPC faced profit booking, defying the broader market trend. |
| Private Banking | 🟡 Mixed | While Kotak Mahindra gained, heavyweights like HDFC Bank and ICICI Bank weighed on the index. |
The Winners and Losers
- The Gainers: Leading the charge were SBI (+7.57%), followed by Titan, UltraTech Cement, and Eternal. Industrial and consumer giants like L&T, Sun Pharma, and IndiGo also saw buying interest.
- The Laggards: High-weightage stocks like ITC, Infosys, and Maruti Suzuki faced resistance, preventing an even sharper climb for the Nifty.
The market’s momentum currently feels underpinned by “The China Plus One” strategy and the solidified trade framework with the US, which appears to be outweighing global inflationary concerns for now.
Would you like me to analyze the specific impact of the India-US trade deal on the IT or Pharmaceutical sectors?
